About Adze Biotechnology
Adze Biotechnology is a private company based in Coral Gables, Florida. It has reported $9,837,505 raised in two offerings on Form D since September 2019. Its chief executive is Sidney Hopps.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2023 | Mar 14, 2023amended Nov 17, 2025 | $6,150,005of $15.0M target | 21 | $292K | EquityRule 506(c) | Form D/A ↗3 earlier filings |
| Dec 12, 2019 | Sep 9, 2019amended May 19, 2022 | $3,687,500fully sold | 19 | $194K | Equity, Debt, Securities on exerciseRule 506(c) | Form D/A ↗5 earlier filings |
| Total, two offerings | $9,837,505 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Adze Biotechnology's Form D filed Nov 17, 2025.
BK
Brendan Kenny
Director
SH
Sidney Hopps
Director and President/CEO
GR
Gabriel Raviv
Director
GI
G. Sage, II
Director
Earlier filings also listed Richard Schuler (director, last listed May 2022), Patrick Sage, II (director, last listed May 2022) and Kenneth Templin (director, secretary and treasurer/cfo, last listed May 2022).
Sources
- SECAdze Biotechnology Inc Form D/A, filed Feb 19, 2025
- SECAdze Biotechnology Inc Form D/A, filed Feb 22, 2024
- SECAdze Biotechnology Inc Form D, filed Mar 14, 2023
- SECAdze Biotechnology Inc Form D/A, filed Nov 19, 2021
- SECAdze Biotechnology Inc Form D/A, filed Mar 31, 2021
- SECAdze Biotechnology Inc Form D/A, filed Dec 14, 2020
- SECAdze Biotechnology Inc Form D/A, filed Dec 19, 2019
- SECAdze Biotechnology Inc Form D, filed Sep 9, 2019
- SECAdze Biotechnology Inc filing history